[{"NetIncomeLoss_1_Q1_USD":-11000000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":8030000.0,"StockRepurchaseProgramAuthorizedAmount1_0_Q1_USD":3800000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":11000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":800000.0,"ProceedsFromCollectionOfNotesReceivable_1_Q1_USD":0.0,"InventoryFinishedGoods_0_Q1_USD":27635000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-2504000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":5400000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":232000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":551600.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q1_shares":29242000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":25328000.0,"ProvisionForLoanLossesExpensed_1_Q1_USD":35000.0,"AssetsCurrent_0_Q1_USD":147367000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":0.0,"LongTermDebt_0_Q1_USD":104946000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q1_USD":6005000.0,"LongTermDebtCurrent_0_Q1_USD":11027000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-21000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":17903000.0,"ContractWithCustomerLiability_0_Q1_USD":0.0,"CostOfGoodsAndServicesSold_1_Q1_USD":119296000.0,"UnrecognizedTaxBenefits_0_Q1_USD":900000.0,"CommonStockSharesIssued_0_Q1_shares":29242000.0,"Assets_0_Q1_USD":506180000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":82000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q1_USD":304000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":-11179000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":613000.0,"InventoryRawMaterials_0_Q1_USD":25794000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-1353000.0,"EarningsPerShareBasic_1_Q1_USD":-0.38,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":29242000.0,"RestructuringCosts_5_Q1_USD":25689000.0,"RestructuringCosts_1_Q1_USD":8404000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-21000.0,"AccountsReceivableNetCurrent_0_Q1_USD":65027000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-4309000.0,"CommonStockValue_0_Q1_USD":29000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":19400000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_1_Q1_USD":4748000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":11000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q1_USD":56900000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":5102000.0,"ContractWithCustomerAssetNet_0_Q1_USD":9100000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.28,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-139000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-17024000.0,"RestrictedCash_0_Q1_USD":193000.0,"IncomeLossFromContinuingOperations_1_Q1_USD":-11000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-6313000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-10696000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":917000.0,"OtherAssetsNoncurrent_0_Q1_USD":1396000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":589000.0,"Liabilities_0_Q1_USD":285022000.0,"ShareBasedCompensation_1_Q1_USD":892000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2508000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":22109000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":4855000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":82000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":892000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":17021000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29242000.0,"InventoryWorkInProcess_0_Q1_USD":6569000.0,"LiabilitiesCurrent_0_Q1_USD":153729000.0,"AccountsPayableCurrent_0_Q1_USD":50722000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":512000.0,"InterestExpense_1_Q1_USD":3109000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":782000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":21753000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-15309000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":-4349000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":9607000.0,"GrossProfit_1_Q1_USD":16347000.0,"FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_1_Q1_USD":169000.0,"AdditionalPaidInCapital_0_Q1_USD":163388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":782000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":12281000.0,"NumberOfOperatingSegments_1_Q1_segment":3.0,"LinesOfCreditCurrent_0_Q1_USD":69000000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":9359000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":978000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q1_USD":-121000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":171413000.0,"LongTermDebtNoncurrent_0_Q1_USD":93919000.0,"Goodwill_0_Q1_USD":69386000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":304000.0,"GainOnBusinessInterruptionInsuranceRecovery_1_Q1_USD":0.0,"TreasuryStockSharesAcquired_1_Q1_shares":0.0,"DeferredFinanceCostsNet_0_Q1_USD":1054000.0,"CommonStockSharesAuthorized_0_Q1_shares":50000000.0,"OperatingIncomeLoss_1_Q1_USD":-12468000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":304000.0,"InventoryNet_0_Q1_USD":59998000.0,"InvestmentIncomeInterest_1_Q1_USD":8000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":477000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":506180000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":8895000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":892000.0,"DeferredFinanceCostsNoncurrentNet_0_Q1_USD":100000.0,"OperatingExpenses_1_Q1_USD":28815000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4997000.0,"StockholdersEquity_0_Q1_USD":221158000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":4623000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":106000000.0,"RestructuringAndRelatedCostExpectedCost1_0_Q1_USD":27000000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":135643000.0,"InvestmentIncomeDividend_1_Q1_USD":281000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":60245000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_1_Q1_USD":-1900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":229000.0,"DeferredFinanceCostsCurrentNet_0_Q1_USD":1000000.0,"CommonStockSharesOutstanding_0_Q1_shares":29242000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.38,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":0.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":4200000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":125000.0,"Ticker":"LNDC","CIK":"1005286","name":"LANDEC CORP CA","OfficialName":"Landec Corporation Common Stock (DE)","form":"10-Q","period":"20200831","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"306028744.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201007"}]